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To evaluate the effects of plasmin on the ZP, SDS-PAGE and zone
pellucida dissolution time (ZPDT) assays were conducted on intact ZP isolated
from bovine ovarian oocytes incubated with plasmin. ZP were incubated with 0
or 100 µg /ml plasmin at 39° C for 0, 24 or 48 h in time course experiments, or
with 0, 100 or 200 pg/m1 plasmin for 0 or 24 h in dose-response experiments.
Following incubation, plasmin was removed from ZP by washing in PBS
containing 0.1% polyvinylpyrrolidone and polyethylenesorbitan monooleate, and
were dissolved in SDS-PAGE sample buffer containing f3-mercaptoethanol and
electrophoresis was performedin10% or12% polyacrylamidegels.
Electrophoretic profiles of the ZP polypeptides were divided into six molecular
weight (MW) classes (>100,000, 75,000-100,000, 60,000-75,000, 26,000-60,000,
20,000-26,000 and <20,000) and evaluated densitometrically. ZPDT assayswere
conducted and plasmin activities were measured during the incubation period.
Redacted for PrivacySDS-PAGE of the bovine oocyte ZP resultedinresolution of two
polypeptides with MW 76,000 and 65,000,respectively, and two minor
polypeptides with MW 23,000 and 22,000 that migrated as a doublet. No
changes occurred in any MW classes in ZP incubated with 0 µg /ml plasmin for
0, 24 or 48 h, and ZPDT were not different (P>0.10). ZP treated with 100 µg/m1
plasmin exhibited decreases in the MW >100,000 and 20,000-26,000 classes at
24 and 48 h. ZPDT were lower (P<0.05) at 24 and 48 h in 100 µg /ml, and
plasmin activities were decreased at 24 and 48 h compared to 0 h (P<0.05).
Bovine ZP treated with 100 or 200 µg/m1 plasmin exhibited a decrease (P<
0.10) in the polypeptides in the MW >100,000 class in 200 µg /ml, and increases
(P<0.10) in the MW 26,000-60,000 and <20,000 classes in 100 and 200 µg /ml
compared to 0 µg /ml plasmin at 24 h. ZPDT were lower (P<0.05) in 100 or 200 t.t.
g/ml compared to 0 µg /ml plasmin at 24 h. ZPDT were also lower (P<0.05) for
ZP treated with 200 µg /ml plasmin compared to 100 µg /ml plasmin. Activity of
both plasmin concentrations was decreased at 24 h (P<0.05).
Inbovine ZP treatedwith50 pg /mlactiveor4-(2-aminoethyl)
benzenesulfonylfluoride-inactivated plasmin at 39° C for 0, 24 or 48 h, decreases
in the MW >100,000 and 75,000-100,000 and increases in the 60,000-76,000 MW
class occurred at 24 and 48 h in active plasmin. Solubility was increased at 24
and 48 h in active plasmin. Compared to 0 µg /ml plasmin, ZPDT were lower (P<
0.05) at 24 and 48 h in inactivated and active plasmin. Caseinolytic activity of
active plasmin was lower (P<0.05) at 48 h compared to 0 and 24 h. Activity of
inactivated plasmin was lower (P<0.05) at 0, 24 and 48 h compared to active
plasmin, but activity of inactivated plasmin increased (P<0.05) at 24 and 48 h.
ZP were also treated with embryonic plasminogen activator. Day 7
embryos(dayofestrus = Day0)werecollectednon-surgicallyfrom
superovulated cows and cultured in Ham's F -12+ 1.5% BSA at 39° C in 5% CO2in air and conditioned medium was collected every 48 h and pooled. Embryo
conditioned medium used to treat ZP contained plasminogen activating activity
equal to approximately 33 IU/m1 human urokinase. ZP treated with non-
conditioned or embryo-conditioned medium for 0 or 48 h at 39° C exhibited no
changes in ZP polypeptide MW classes (P>0.10). ZPDT were not different
between non-conditioned and embryo-conditioned medium at 0 and 48 h (P>
0.10). Addition of human plasminogen (100 pg/m1) to embryo-conditioned
medium resulted in a decrease in the MW 75,000-100,000 class and an increase
in the <20,000 class at 48 h (P<0.10). These results demonstrate that bovine
plasminis capable of proteolytically degrading the bovine ZP, and that
embryonic plasminogen activator is capable of activating plasminogen in the
presence of the ZP, thereby indirectly affecting the ZP through activation of
plasminogen to plasmin. Changes in the specific MW classes and decreases in
ZPDT suggest that the plasminogen activator/plasmin system could exert
proteolytic effects on the ZP during fertilization and hatching.EVALUATION OF ALTERATIONS IN THE BOVINE ZONA
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INTRODUCTION
Preimplantation embryonic development in mammalian species involvesa
complex set of processes that begin with fertilization, and that end withthe
implantation or attachment of the developing embryo to the uterus. Duringmost
of this period the embryo is surrounded by a protein coat called thezona
pellucida (ZP). The ZP is an acellular glycoprotein matrix thatserves multiple
functions in the preimplantation period of development. During fertilization,the
ZP functions as a sperm receptor and also induces theacrosome reaction in
fertilizing sperm cells, allowing them to penetrate the ZP (Wassarman,1988).
Immediately following fertilization, the ZP undergoes an event knownas "zona
hardening", which makes it impenetrable by furthersperm, thereby serving as a
block to polyspermy (Hoodbhoy and Talbot, 1994). The ZP also maintainsthe
integrity and conserves the microenvironment of the developingembryo
(Betteridge and Flechon, 1988). At some point however, the embryomust shed
the ZP for normal development to proceed. Prior to implantation,the embryo
escapes from the ZP in a process known as hatching (Betteridge and Flechon,
1988).
Plasminogen activators (PA) are serine proteases thatare capable of
activating the tissue zymogen plasminogen to the broad-spectrumserine2
protease plasmin (Dano et al., 1985). There are two main types of PA in
mammalian species, each having a different physiologic function: t-PA, which is
mainly involved in lysis of fibrin clots in the circulatory system; and u-PA, which is
primarily involved in extracellular matrix degradation during tissue migration, and
is known to be associated with a number of invasive or migrating cell types
(Dano et al., 1985; Saksela and Rifkin, 1988). PA are also known or suspected to
be involved in a number of reproductive processes. In the male, both types of
PA are involved in different processes in spermatogenesis (Lacroix et al., 1981;
Tolli et al., 1995), and in the female PA are involved in ovulation (Beers, 1975;
Canipari and Strickland, 1985; Ny et al., 1985).
The PA/plasmin system may also be involvedin other aspects of
reproduction. Fertilization is a process that up until recently was felt to be
dependent on the protease acrosin for sperm to penetrate the ZP. However, it
has recently been shown that fertilization can occur without acrosin (Baba et al.,
1994). Since both sperm and oocytes are known to secrete PA, and addition of
plasminogen to in vitro fertilization media increases fertilizationrates, this
suggests that the PA/plasmin system may facilitate penetration of the ZP by
sperm during fertilization (Huarte et al., 1993).
The mechanisms used by the embryo to hatch have long been a source of
debate. Early on it was proposed that the embryo caused the rupture of the ZP
through hydrostatic pressure generated by the expanding blastocoel combined
with proteolytic weakening of the ZP (McLaren, 1970). Also, it was observed that
the ZP of uterine embryos exhibited changes in solubility prior to hatching,
suggesting that a zonalytic agent in the uterus catalyzed a "sublysis" of the ZP,
which weakened it and facilitated hatching (Domon et al., 1973). Subsequently it
was observed that the embryo secretes a trypsin-like protease prior to hatching,
and that activity of this enzyme is found associated with the ZP following3
hatching, with the greatest intensity at the point of rupture (Perona and
Wassarman, 1986). It is known that the embryo secretes PA (Stick land et al.,
1976; Fazleabas et al., 1983), is capable of activating plasminogen to plasmin
(Menino and Williams, 1987; Menino et al., 1989) and that embryos which
produce more PA are more likely to hatch (Kaaekuahiwi and Menino, 1990).
Also, culture of embryos in medium containing plasminogen results in increased
solubility of the ZP. These results suggest that the PA/plasmin system is
involved in the hatching process.
Implantation is a process which involves the invasion of the uterine cell
layers by cells from the developing embryo. This process has been describedas
very similar to tissue invasion by metastatic tumors, which is known to involve
proteases, particularly PA (Strickland, 1980; Dano et al., 1985). PA secretion is
correlated to the invasive period of development of the trophoblast (Strickland et
al., 1976), and is localized to the regions of the trophoblast which are invading
the uterine tissue (Sappino et al., 1989). The trophoblast alsoexpress a PA
receptor on the cell surface, but only during the invasive period (Zini et al.,
1992). Also, trophoblast cells that are incapable of removing inactive PA-inhibitor
complexes from their surface are incapable of implanting (Herz et al., 1992). It
therefore seems that implantation is another event in which the PA/plasmin
system is in some way involved.
Based on the evidence supporting the involvment of the PA/plasmin
system in fertilization and early embryo development, the objective of this thesis
was to evaluate changes in zona pellucida integrity following exposure to
plasmin or the embryonic plasminogen activator.4
REVIEW OF THE LITERATURE
The Zona Pellucida
In mammalian species, the female gamete, the oocyte, is surrounded by
an acellular glycoprotein coat at the time of ovulation. This glycoprotein coat, the
zona pellucida (ZP), serves functional roles in both the oocyte as well as the
early embryo. The (ZP) is composed of multiple glycoprotein components
(Wassarman, 1988) that are products of developmentally regulatedgenes
(Dean, 1991) and which display antigenic cross-reactivity (Maresh and Dunbar,
1987) and biochemical similarities (Wassarman, 1988) across species. Although
the ZP may serve more as yet unknown functions, components of the ZP have
been demonstrated to be involved in fertilization as sperm receptors, in induction
of the acrosome reaction, and in the post-fertilization block to polyspermy
(reviewed by Wassarman, 1988). Also, the ZP is essential in maintaining the
physical integrity of the early embryo up to the fully-compacted late-morula
stageandhas been suggestedtoplayaroleinconservingthe
microenvironment of the perivitelline space in some species (Betteridge and
Flechon, 1988).
Growth and development of the oocyte occurs in conjunction with growth
and development of the ovarian follicle during folliculogenesis. Folliculogenesis
will not be extensively reviewed; it will suffice to say that follicle development
proceeds from the primordial stage (the least mature) through the primary,
secondary, and tertiary follicle stages, and finally to the Graafian,or pre-5
ovulatory follicle. These stages involve dynamic histological and biochemical
changes in the follicle which are much more complex than development of the
oocyte.
In most mammalian species studied (the rabbit being an exception), the
ZP is completely formed at the time of ovulation. However, it has been observed
that oocytes isolated from primordial ovarian follicles are bounded only by a
plasma membrane, and do not display a ZP (Chiquoine, 1960). Histologically the
first evidence of formation of the ZP is seen on oocytes contained in late primary
follicles. The ZP is not formed uniformly around the oocyte, but first appears as
discontinuous portions around the oocyte, which later fuse to form a continuous
glycoprotein coat. As the oocyte and follicle continue to grow and develop, the
ZP begins to thicken and take on a uniform appearance. By the time the follicle
reaches the tertiary stage, the ZP is completely formed (Hafez, 1993).
Since the oocyte is encased within an ovarian follicle and the follicle cells
are intimately associated with the oocyte, this observation led to some early
contention as to the cellular origin of the ZP (Haddad and Nagai, 1977). It was
suspected from initial morphological and histochemical studies that the source
of the ZP was the follicle cells immediately surrounding the oocyte (reviewed by
Wassarman, 1988). However, in studies in which oocytes from primordial
follicles were denuded of follicle cells and placed in culture, it was observed that
the oocytes were capable of secreting the ZP glycoproteins, whereas cultured
follicle cells were not (Bleil and Wassarman, 1980). Further, in pulse-chase
autoradiographic studies in which mice were injected with radioactive fucose, it
has been observed that the radioactive label appears first in the ZP adjacent to
the oocyte plasma membrane, and subsequently progresses towards the outer
surface of the ZP as the oocyte grows (Haddad and Nagai, 1977; Flechon et al.,
1984).6
Expression of the mRNA coding for components of the ZP has also been
used to investigate not only the site of synthesis of the ZP, but also the
developmental stages at which the ZP components are expressed. Synthesis of
the ZP glycoproteins is not only limited to the oocyte, but expression of the
genes coding for the ZP is developmentally regulated to only those oocytes in
the growth phase. In 1986, Ringuette and coworkers created a murine oocyte
cDNA library, and cloned a cDNA coding for a component of the mouse ZP, ZP-
3. This cDNA was then used to demonstrate that mRNA for the ZP-3
glycoprotein is only expressed in the oocyte (Ringuette et al., 1986). This cDNA
was subsequently used to demonstrate that ZP-3 is expressed only in growing
mouse oocytes, and not in resting mouse oocytes (Ringuette et al., 1988).
These researchers further showed that another component of the mouse ZP,
ZP-2,iscoordinatelyexpressedwithZP-3,andthatexpressionis
developmentally restricted to oocytes in the growth phase (Liang et al., 1990).
One notable feature of the ZP is the differences between the inner and
outer surfaces. Scanning electron micrographs reveal that the outside surface of
the ZP is not a solid surface, but has the mesh-like appearance of a sponge.
This is different from the inside surface, which is more uniform in appearance
with no mesh-like fenestrations (reviewed by Hafez, 1993). Flechon and
coworkers have suggested that the fenestrated appearance of the outer surface
of the ZP is a consequence of the increase in the outer diameter of the ZP due to
accretion of new material from the inside (Flechon etal.,1984). These
observations suggested that the ZP is not an impermeable barrier, andare
reinforced by studies which show that the ZP is permeable to macromolecules
such as ferritin (molecular weight (MW) 480,000 to 1,000,000) (Hastings et al.,
1972) and immunoglobulins (Sellens and Jenkinson, 1975).7
Biochemically, the mammalian ZP is made up of a relatively small number
of different glycoproteins. Due to the ease of isolation of large numbers of
oocyte ZP, the most extensively studied ZP are the porcine and murine ZP.
However, biochemical and immunological similarities have been demonstrated
between ZP from these species and rat, hamster, rabbit, cat, dog, squirrel
monkey, and human ZP (Maresh and Dunbar, 1987; Wassarman, 1988).
The murine ZP is composed of three glycoproteins, ZP1, ZP2, and ZP3,
with MW of 200,000, 120,000 and 83,000, respectively, as determined by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). All of these
glycoproteins are acidic, with pl between 4.1 and 5.5. Under native conditions
ZP2 and ZP3 are monomers, while ZP1 is a dimer. In the presence of reducing
reagents on SDS-PAGE, ZP1 has an apparent MW of 120,000 and comigrates
with ZP2, suggesting that the dimer is held together by intermolecular disulfide
bonds. Migration of ZP3 is slightly retarded, suggesting that the native form
possesses intramolecular disulfide bonds (Wassarman, 1988).
SDS-PAGE of the porcine ZP under reducing conditions yields four
glycoproteins, ZP1, ZP2, ZP3, and ZP4, of molecular weight 80,000-90,000,
60,000-65,000, 55,000, and 20,000-25,000, respectively (Dunbar and Raynor,
1980; Dunbar et al., 1980; Hedrick and Wardrip, 1986). Like the murine ZP
glycoproteins, the porcine ZP components are acidic, with pl between 5.2 and
5.6 pl units. Under non-reducing conditions, SDS-PAGE of the porcine ZP
reveals only two glycoproteins, with molecular weights of 80,000-90,000 and
55,000. Since the sum of the molecular weights of ZP2 and ZP4 equal that of
ZP1, this suggests that ZP2 and ZP4 are derived from ZP1 due to reduction of
intermolecular disulfide bonds (Yurewicz et al.1987; Hedrick and Wardrip,
1987a). Also, the amino acid and carbohydrate compositions of ZP2 and ZP4
equal ZP1, and ZP1 is immunologically related to ZP2 and ZP4. ZP2 and ZP4 are8
not immunologically related (Wassarman, 1988). Together these observations
suggest that ZP1 and ZP3 are the actual native porcine ZP glycoproteins.
Interestingly, there are actually two forms of porcine ZP3, designated as
ZP3a and ZP36. Deglycosylation of ZP3 yields two different polypeptides of MW
35,000 and 38,000 (Yurewicz et al., 1987) and antigenic studies reveal that ZP3a
and ZP36 are immunologically distinct (Timmons et al., 1987). These findings
suggest that there are two structurally and immunologically distinct ZP3
glycoproteins, which are presumably encoded by different genes (Wassarman,
1988). Collectively, these data suggest that the intact porcine ZP is composed of
three distinct glycoproteins: ZP1 (82,000), ZP3a (55,000), and ZP36 (55,000)
(Sacco et al., 1989).
Electrophoretic analysis of the bovine ZP under reducing conditions by
Gwatkin and coworkers (1980) resulted in three glycoprotein components, with
molecular weights of 100,000, 50,000, and 25,000. However, an electrophoretic
comparison of bovine ZP under reducing and non-reducing conditions by
Menino and Wright (1980) resulted in a single glycoprotein band of MW 73,000
under non-reducing conditions. Under reducing conditions, electrophoresis of
the bovine ZP resulted in two major bands with molecular weights of 15,000 and
22,000. This led these authors to conclude that the bovine ZP is composed of a
single protein, made up of four subunits, two of MW 15,000 and two of MW
22,000, held toether by intermolecular disulfide bonds (Menino and Wright,
1980). More recently two dimensional gel electrophoresis of the bovine ZP under
non-reducing conditions resultedinthe resolutionof three glycoprotein
components with varying ranges of pl: 94,000-110,000, pl= 7.0-8.3, 82,000-
94,000, pl= 4.3-4.8 and 70,000-76,000, pl= 5.8-7.3 (Florman and First, 1988).
Electrophoretic analysis of the bovine ZP under reducing conditions resulted in9
resolution of three major glycoprotein bands with MW approximately 100,000,
80,000, and 65,000, and two minor bands with MW 21,000 and 22,000 (Cannon
and Menino, 1995).
Electrophoretic mobilities and isoelectric points of the ZP components can
be significantly altered by various agents which are capable of removing
oligosaccharides from the glycoproteins. Digestion of murine ZP with endo-0-N-
acetylglucosaminidase F (Endo F), which removes high-mannose- and complex-
type, asparagine-linked (N-linked) oligosaccharides, results in an increase in
electrophoretic mobilities and an increase in isoelectric points of all three murine
ZP glycoproteins. Also, alkaline 0-elimination, which removes serine/threonine-
linked (0-linked) oligosaccharides, results in increased electrophoretic mobilities
of ZP2 and ZP3. Treatment with neuraminidase, which releases terminal sialic
acid residues from oliogosaccharides,resultsindecreasesinapparent
molecular weight of the murine ZP components by 6,000-7,000 each, and
increases in isoelectric points of as much as 1.1 pl units (Wassarman et al.,
1988). These observations indicate that the murine ZP glycoproteins contain
both N- and 0-linked, high-mannose oligosaccharide chains, as well as terminal
sialic acid residues on the oligosaccharides.
Similarly, chemical deglycosylation of porcine ZP glycoproteins results in
decreases in apparent molecular weights of all ZP components (Wassarman et
al., 1988). Yurewicz and coworkers (1991) demonstrated that ZP3 is heavily
glycosylated with variably sized N- and 0-linked sulfated polylactosamines. Later
it was demonstrated that the 0-linked oligosaccharides of porcine ZP3are
clustered within limited domains, rather than being widely dispersed along the
polypeptide backbone (Yurewicz et al., 1992). These researchers concluded
that this clustering may represent an essential determinant of biological activity
of the ZP glycoproteins (Yurewicz et al., 1992).10
The mammalian ZP performs a number of biological functions in the
oocyte and the early embryo. The first of these is the role of sperm receptor.
Murine ZP3 has been shown to be the primary sperm receptor. It has been
shown that purified ZP3 will bind to intact mouse sperm, but not toacrosome-
reacted sperm, and acrosome reacted sperm are incapable of binding to ZP
(Wassarman, 1988). Further, it has been reported that a ZP receptoron the
inner acrosomal membrane binds to ZP2 to maintain binding ofacrosome
reacted sperm to the ZP. Thus, ZP2 seems to act asa secondary sperm
receptor in the mouse (Mori et al., 1995). In the pig, sperm receptor activity has
been shown to be associated with ZP3a (Sacco et al., 1989).
The ZP glycoproteins are also responsible for inducing theacrosome
reaction in sperm following sperm binding. Purified murine ZP3 is capable of
inducing the acrosome reaction in free-swimming mouse sperm (Wassarman,
1988). Bovine ZP glycoproteins will induce the acrosome reaction in capacitated,
but not non-capacitated sperm (Florman and First, 1988).
It has been demonstrated that the oligosaccharide side chains foundon
the glycoprotein components of the ZP are necesary for sperm receptor activity.
Sacco and coworkers (1989) treated porcine ZP3 glycoproteins with antisera
raised against either native or deglycosylated porcine ZP. Boar spermwere then
exposed to these glycoproteins prior to use in ZP binding assays. These
researchers observed that sperm exposed to ZP glycoproteins treated with
antisera against native ZP were incapable of binding to ZP. Sperm thatwere
exposed to ZP glycoproteins treated with antisera against deglycosylated ZP
retained the ability to bind to ZP. This led to the conclusion thatsperm binding of
the ZP was dependent on the oligosaccharides presenton the ZP glycoproteins
(Sacco et al., 1989). Subsequently, it was shown that 0-glycans isolated from
purified porcine ZP3a are capable of inhibiting sperm binding to the ZP, and11
these 0-glycans compete with ZP3a in sperm-ligand binding assays (Yurewicz
et al., 1991). This suggests that sperm binding to the ZP, which occurs at
fertilization,ismediated by ZP3ainthepig,and thatthe0-linked
oligosaccharides on ZP3a are necesary for sperm binding.
Following sperm binding and fertilization, an event known as the cortical
granule reaction takes place. Cortical granules are membrane-bound organelles
in the oocyte which contain a variety of proteolytic enymes. During the cortical
granule reaction, the cortical granules fuse with the oocyte plasma membrane
and release their contents into the perivitelline space (Hoodbhoy and Talbot,
1994). ZP glycoproteins isolated from zygotes exhibit different properties than
those isolated from oocytes (Hedrick et al., 1987). Enzymes released during the
cortical granule reaction are capable of modifying ZP glycoproteins. In the
mouse, ZP3 loses the ability to bind sperm and induce the acrosome reaction.
Also, ZP2 is proteolytically modified to a form called ZP2f, which contains small
peptide fragments which remain covalently attached to the glycoprotein by
disulfide bonds. Treatment of ZP2f with reducing reagents will release the
peptide fragments and yield a MW 90,000 glycoprotein (Wassarman, 1988). In
the pig, the number of MW 90,000 minor glycoproteins seen on SDS-PAGE gels
decreases substantially following fertilization. At the same time, sperm receptor
activity of the ZP decreases (Hatanaka et al., 1992). In both cases, ZP from
fertilized oocytes are more resistant to solubilization by detergents, strong
proteases, or acidic solutions, demonstrating the "zona hardening" effect of the
cortical granule reaction (Wassarman, 1988; Hatanaka etal.1992). This
suggests that the proteases released by the cortical granules modify the ZP,
removing the sperm receptor activity and making the ZP more resistant to
further sperm penetration, thereby leading to a block to polyspermy (Hatanaka
et al., 1992).12
It is evident that the ZP is a complex structure which servesa number of
important functions in the oocyte and the early embryo. Proteolytic modification
of the ZP during the cortical granule reaction is necesary toensure that the
oocyte is not fertilized by more than one sperm, thereby allowing development
to proceed normally. However, this is not the only proteolytic event involving the
ZP. Proteolysis of the ZP is involved in penetration of the ZP bysperm (Dean,
1992), and may also be involved in shedding of the ZP by the developing
embryo, a process known as hatching (Perona and Wassarman, 1986). In
particular the plasminogen activator/plasmin proteolytic system has been
implicated to be involved in both of these processes (Huarte et al., 1993; Menino
and Williams, 1987).
The Plasminogen Activator/Plasmin System
Kaplan (1944) and Christensen (1945) first describedan inactive form of a
fibrinolyticenzyme,designatedasprofibrinolysinorplasminogen,and
demonstrated that this enzyme could be converted to an active protease called
fibrinolysinor plasmin.Following theseearlyreports,the presence of
substances able to activate plasminogen to plasmin was demonstrated in tissue
and tissue extracts, blood, and urine. These plasminogen-activating substances
were later found to be proteolytic enzymes, and it was shown that conversion of
plasminogen to plasmin occurred through limited proteolysis of plasminogen
(reviewed by Dano et al., 1985).
Plasminogen activators (PA) are now known to be serine proteases which
use plasminogen as their primary substrate. Two main types of structurally13
similar yet functionally and immunologically distinct PA, which are products of
different genes, have been characterized in the vertebrate: urokinase-type PA
(u-PA), originally isolated from urine; and tissue-type PA (t-PA) originally isolated
from tissue extracts. Additionally, serine proteases other than u-PA and t-PA
have been shown to be capable of activating plasminogen. These include serum
kallikrein, blood coagulation factors XI and XII, and very high molecular weight
plasminogen-activating proteases characterized in various tumor cell lines (Dano
et al., 1985; Saksela and Rifkin, 1988).
PA from non-vertebrate sources have also been identified. Strains of E.coli
have been reported to contain membrane-bound serine proteases capable of
activating plasminogen. Streptokinase is a bacterial protein capable of activating
plasminogen, however the mechanism of action is completely different from the
vertebrate PA. It acts by complexing with plasminogen, and this complex then
has plasminogen activating capability. Amino acid sequence analysis shows that
it has homology with serine proteases, but it lacks the active site histidine (Dano
et al., 1985).
The group of proteases known as the serine proteases, of which plasmin,
u-PA, and t-PA are all members, are involved in a diverse range of cellular and
physiological functions, including blood clotting and clot lysis, pro-hormone
processing, complement activation, fertilization, and ovulation (Strickland, 1980;
Dano et al., 1985;). The serine proteases are divided into two families which are
structurally very different, but which share the same active site and mechanism
of action: the subtilisin family, and the trypsin family, which includes plasmin and
PA (Branden and Tooze, 1991).
Serine proteases all share a common amino acid motif in their active sites.
Aspartic acid, histidine, and serine residues comprise the active site, and
together they form a system which is refered to as the charge-transfer relay14
system, more commonly called the catalytic triad. The serine proteasesuse this
system to catalyze the hydrolysis of peptide bonds in polypeptides and proteins
(Kraut, 1977). The specificity of the serine proteases for differentsubstrates,
however, is due to features other than the active site. To describe thespecificity
of a protease designates the position of amino acid residues in thesubstrate
relative to the peptide bond to be cleaved:
-A4-A3-A2-Al -A' 1-A'2-A'3-
-A4-A3-A2-A1-0H + H-A'1-A'2-A'3-
The serine proteases catalyze the hydrolysis of peptide bonds invery similar
ways, but they differ strikingly in their specificity for the amino acid residue at
position Al (Creighton, 1993).
Plasminogen is the zymogen form of the serine protease plasmin. This
inactive proenzyme is produced in the liver, and is present in plasmaat a
concentrationof approximately180fig/m1.Ithas been reportedthat
approximately 40% of the total plasminogen in an organism is extravascular.
Plasminogen has been found in a variety of locations, including follicular fluid,
uterine fluid, saliva, and the basal layers of the epidermis (Dano et al., 1985).
Native plasminogen exists as a single polypeptide chain witha molecular
weight of 92,000. This form of plasminogen is termed Glu-plasminogenbecause
the amino terminal residue is glutamine. Glu-plasminogencan by proteolytically
modified to a form called Lys-plasminogen by cleavage of theLys76-Lys77 bond
by plasmin. This form of plasminogen has lysine at the amino terminus,and has
a molecular weight 8,000 lower than Glu-plasminogen. Plasminogen activation is
the result of the specific cleavage of the Arg560-Va1561 peptidebond by PA.15
GLu- and Lys-plasminogen are converted to Glu- and Lys-plasmin, respectively,
which are capable of converting Glu-plasminogen to Lys-plasminogen, and Glu-
plasmin to Lys-plasmin. Active plasminis almost exclusively Lys-plasmin
(Christman et al., 1977; Dano et al., 1985).
Plasmin has a broad trypsin-like specificity, and hydrolyzes proteins at
lysyl and arginyl bonds (Robbins et al., 1973; Dano et al., 1985). Active plasmin
is composed of two polypeptide chains linked by a disulfide bond. The light
chain, or B-chain, is derived from the carboxyl terminus and has a MW of
approximately 25,000. It contains the active site and has amino acid sequence
homology with other serine proteases. The heavy chain, or A-chain, is derived
from the amino terminus, and has a MW of approximately 60,000. The A-chain is
catalytically inactive, and contains five cysteine-rich, triple disulfide structural
domains called kringles. Kringles are considered essential for binding to
extracellular matrix-like proteins. Both plasminogen and plasmin display affinities
for fibrin, as well as for other extracellular matrix molecules. Binding of
extracellular matrix molecules may occur via the kringle domains, and may serve
to immobilize the protease and protect it from inactivation (Saksela and Rifkin,
1988).
Activation of plasminogen to plasmin is carried out by PA, which are also
serine proteases belonging to the trypsin family. The two types of PA, u-PA and
t-PA, are structurally very similar and activate plasminogen in the same manner.
However, they are functionally, immunologically and biochemically distinct, and
are products of different genes.
t-PA has been identified in plasma, saliva, tears, seminal plasma, uterine
fluid, in small amounts in urine, and in varying amounts in all tissues. t-PA is a
basic glycoprotein with a MW of approximately 70,000 and pl =8. t-PA can be
found in two forms, a single chain form (sct-PA) and a two-chain form (tct-PA),16
the latter being the proteolytically active form. Conversion of sct-PA to tct-PA is
catalyzed by plasmin, tissue kallikrein, and blood coagulation factor Xa. tct-PA
contains a heavy chain, or A-chain, with a MW of 40,000, and a light chain, or B-
chain, with a MW of 30,000, linked by disulfide bonds. The B-chain contains the
active site, with the catalytic triad of His322, Asp371, and Ser478 being
homologous to the active sites found in other serine proteases. The A-chain
contains other domains which relate to the physiological activities of t-PA. Within
the A-chain are a fibronectin-like finger domain, an epidermal growth factor-like
domain, and two kringle domains. The fibronectin-like finger domain and the
second krigle domain are responsible for the high affinity of t-PA for fibrin.
The major physiological function of t-PA is in thrombolysis. This is most
evident due to the fact that binding of t-PA to fibrin enhances enzymatic activity
and results in increased conversion of plasminogen to plasmin. Also, t-PA but
not u-PA is present in vascular endothelium, and the concentration of t-PA in the
blood is greatly increased following venous occlusion (Dano et al., 1985).
u-PA was first discovered in urine, but was later found in small amounts in
blood plasma and seminal plasma. u-PA was also found to be produced by a
wide variety of neoplastic tumors and other migrating cell types. u-PA is a basic
glycoprotein with MW of approximately 50,000, and pl between 8.4 and 9.7. Like
t-PA, it exists in two forms, a single chain form (scu-PA) and a two-chain form
(tcu-PA). tcu-PA is the active enzyme, and conversion from scu-PA to tcu-PA is
catalyzed by plasmin. tcu-PA contains a heavy chain or B-chain, with a MW of
30,000, and a light chain or A-chain, with a MW of 20,000, linked by a single
disulfide bond. The A-chain contains a single kringle domain near the carboxyl
terminal, and an epidermal growth factor-like domain at the amino terminal.
There is no fibronectin-like finger domain corresponding to that found in t-PA.
The B-chain contains the active site, where His204, Asp255 and Ser35617
comprise the catalytic triad. These are in homologous positions to other serine
proteases of the trypsin family. u-PA can also be further modified by plasmin to a
molecule with a MW of 33,000. This form of u-PA contains a B-chain identical to
the B-chain of the MW 50,000 form, and a truncated version of the A-chain which
contains the C-terminal 21 amino acids. This form of u-PA lacks the epidermal
growth factor-like domain and the kringle domain, but retains full enzymatic
activity (Dano et al., 1985; Saksela and Rifkin, 1988).
Physiologically, the major importance of u-PA seems to be extracellular
matrix degradation during tissue remodelling. For example, u-PA has been
detected in decidual cells, in cells of the involuting mammary gland, and in
invasive cells of the trophoblast (Sherman, 1980). Further, invasive tumor cells
and cells which have been transformed by oncogenic viruses have been shown
to secrete large amounts of u-PA (Dano et al., 1985).
The role of u-PA in degradation of extracellular matrix components and
tissue remodelling is supported by the existence of a high affinity receptor for u-
PA which does not bind t-PA. This receptor binds u-PA via the epidermal growth
factor-like domain. tcu-PA bound to the receptor retains full catalytic activity. The
receptor has been found on several invasive cell types, including macrophages,
monocytes, and several malignant cell types, as well as on sperm cells (Vassal'
et al., 1984; Huarte et al., 1987). Binding of u-PA to the receptor localizes PA
activity to the cell surface, and most likely facilitates the migration of invasive
cells. In cells secreting u-PA and expressing the receptor, this mechanism would
act in an autocrine fashion to facilitate cell migration. Cells not secreting u-PA but
expressing the receptor may also bind u-PA from other sources, thereby utilizing
u-PA mediated proteolytic machinery in cell migration (Huarte et al.,1987).
There is also evidence that PA can proteolytically modify other substrates.
Neurons in the developing rat dorsal root ganglia secrete u-PA, and u-PA18
stimulates the proliferation of Schwann cells in a dose-dependent fashion. This
mitogenic effect is observed in the absence of plasminogen, which suggests that
the substrate for PA in this system is not plasminogen (Baron-Van Evercooren,
1987). u-PA has also been shown to cleave a MW 66,000 protein in the
pericellular matrices of human lung fibroblasts (Keski-Oja and Vaheri, 1982).
These observations demonstrate that although plasminogen is the primary
substrate, PA is capable of catalyzing limited proteolysis of other substrates.
The Plasminogen Activator/Plasmin System
In Reproduction
Male Reproduction
In the male, PA is thought to be involved in spermatogenesis by facilitating
movement of the germ cells from the basement membrane of the seminiferous
tubule, through the tight junctions between Sertoli cells to gain entry to the
adluminal compartment of the seminiferous tubule. PA has also been suggested
to be involved in release of the sperm cells into the lumen of the seminiferous
tubule, or spermiation. Lacroix and coworkers (1977) observed that enriched
cultures of Sertoli cells secreted PA, and that the production of PA was
stimulated by follicle stimulating hormone (FSH) and dibutyryl cyclic adenosine
monophosphate (dbcAMP). Subsequently, Lacroix and coworkers (1981) found
that during spermiation in the rat (which occurs during stages VII and VIII of the
cycle of the seminiferous epithelium) PA activity in the seminiferous tubules was
much greater than at any other stage of the cycle of the seminiferous epithelium.19
This stage of the cycle of the seminiferous epithelium inthe rat also corresponds
to the time of movement of Sertoli cellprocesses to surround leptotene
spermatocytes. This suggests that PA is involved in bothspermiation and
remodeling of the Sertoli cells during spermatogenesis(Lacroix et al., 1981).
Organ culture of rat seminiferous tubule and cultureof purified Sertoli cells
demonstrates that under basal conditions Serto li cellsproduce u-PA, whereas in
response to FSH or dbcAMP stimulation, u-PA production decreasesand t-PA
production increases (Nettle et al., 1986; To lli et al., 1995).Examination of Sertoli
cell plasma membranes also supports the data thattwo types of PA are
synthesized by the Serto li cell, one being associated withthe plasma membrane
and the other secreted (Marzowski et al., 1985). Investigationof the types of PA
present in cells of the seminiferous tubule and the specifictimes at which they
are present revealed that u-PA is present during stages VII-VIII ofthe cycle,
whereas t-PA is present during stages VII-XIII (Vihkoet al., 1988). Collectively
these data seem to support the current hypothesis that thetwo types of PA play
different roles in spermatogenesis. u-PA is thoughtto be involved with tissue
remodeling during the releaseof pre-leptotene spermatocytes from the
basement membrane of the seminiferous tubule,encasement of leptotene
spermatocytes within Sertoli cell processes and spermiation. t-PA isfelt to be
involved with opening of Sertolicelltight junctions during migration of
spermatocytes from the basal to the adluminalcompartment of the seminiferous
tubule (To Ili et al. 1995).Female Reproduction
Ovulation
20
PA is involved in rupture of the Graafian follicle at the time of ovulation.
Prior to the time of ovulation, the follicle wall is made up of two cell layers; the
stratum granulosa, which is interior to the second layer, the theca folliculi. The
majority of the follicle is made up of a fluid filled-cavity called the antrum. Fluid
within the antrum (follicular fluid) has been shown to contain plasminogen in
approximately the same concentration as that found in blood (Beers, 1975). It
has also been shown that plasmin is capable of reducing the tensile strength of
the follicle wall and that PA is present in the follicular fluid and follicle wall.
Granulosa cells collected from follicle walls during different stages of the estrous
cycle exhibited peak PA activity prior to ovulation (Beers, 1975). In short term
culture of cells collected from pre-ovulatory and non-ovulatory follicles, only cells
from pre-ovulatory follicles exhibited PA activity (Strickland and Beers, 1976).
Both types of PA have been detected within the follicle. Inone study,
granulosa cells were shown to produce t-PA, whereas thecal cells produced
only u-PA (Canipari and Strickland, 1985). However, other data suggest that the
granulosa cells produce both u-PA and t-PA (Ny et al., 1985). Further, PA
production by these cells seems to be effected by the pituitary gonadotropins
follicle stimulating hormone (FSH) and luteinizing hormone (LH). Canipari and
Strickland (1985) observed that granulosa cells produce increased amounts of t-
PA under stimulation by FSH, whereas u-PA secretion by the thecal cellswas
not altered by FSH. However, LH stimulated u-PA production by thecal cells.
Alternatively, Ny and coworkers (1985) found that FSH and LH stimulated t-PA
production by the granulosa cells, but u-PA activity was not affected. Both21
studies observed that FSH stimulated t-PA production by granulosa cells, and
that LH stimulation resulted in some form of increased PA activity.
In intact follicles, PA activity increases in response to treatment of animals
with FSH and LH (Reich et al., 1985). These authors also found that injection of
serine protease inhibitors into the ovary will inhibit ovulation (Reich et al., 1985).
PA activity in the walls of follicles that have ovulated is higher than that found in
the walls of growing and mature follicles, and the highest PA activity is foundat
the area of the rupture (Somokovitis et al., 1988). These observationssuggest
that as the time of ovulation approaches increased gonadotropin stimulation of
the granulosa and thecal cells stimulates production of PA. The increased PA
activity leads to increased production of plasmin, leading toproteolytic
degradation and weakening of the follicle wall, which facilitates ovulation.
Fertilization
During mammalian fertilization, sperm bind to the oocytezona pellucida
via the primary sperm receptor component of the ZP. This binding of the sperm
to the ZP triggers fusion of the sperm plasma membrane and the outer
acrosomal membrane, an event known as the acrosome reaction. The
acrosome reaction results in the release of the lytic enzymes in the acrosome, of
which acrosin is the most abundant, as well as exposure of lyticenzymes
associated with the inner acrosomal membrane (reviewed by Dean et al., 1992).
It is felt that at the time of the acrosome reaction, acrosin acts locally to
degrade the ZP glycoprotein matrix allowing the sperm to penetrate the ZP.
Acrosin has been shown to be capable of limited proteolysis of specific22
components of the ZP (Dunbar et al., 1985). Also, it is felt that proacrosinmay
have some role to play in sperm binding to the ZP and retention ofacrosome-
reacted sperm on the ZP (Jones, 1990). Further, ZP glycoproteins increase the
rate of conversion of pro-acrosin to acrosin, as well as increasing the activity of
acrosin (Lo Leggio et al., 1994).
Recently it has been shown that acrosin is not essential for penetration of
the ZP at fertilization. Baba and coworkers (1994) have demonstrated that
transgenic mice, in which acrosin is made non-functional through targeted
mutagenesis of the acrosin gene, are still fertile.In vitro fertilization studies
comparing sperm from wild-type and mutant mice revealed no differences in
fertilization rate, however sperm penetration of the ZP was slower in the mutant
mice (Baba et al., 1994). This suggests that although acrosin is probably
involved in proteolysis of the ZP during sperm penetration, other proteasesare
most likely involved since acrosin is not absolutely essential. Also, various
trypsininhibitors are cablable of markedly reducing sperm binding and
penetration of the ZP at fertilization (Saling, 1981). These observations seem to
suggest the involvement of trypsin-like serine proteases besides acrosin in
penetration of the ZP by fertilizing sperm.
Ithas been suggested that the PA/plasmin systemisinvolvedin
fertilization (Huarte et al., 1993). Ovulated oocytes produce t-PA (Huarte et al.,
1985, 1993). In vitro fertilization of oocytes isolated from follicles with high t-PA
content in the follicular fluid resulted in a higher percent of successfully fertilized
oocytes than fertilization of oocytes from follicles in which t-PA in the follicular
fluid was low (Deutinger et al., 1988).
Ejaculated spermatazoa possess the u-PA receptor and exhibit u-PA
activity (Huarte et al., 1987), and binding of plasminogen to cell surfaces has
been shown to enhance the conversion of plasminogen to plasmin (Miles and23
Plow, 1985). Both spermatazoa and oocytes bind plasminogen, and bothare
capable of converting plasminogen to plasmin (Huarte et al., 1993). Further, in
the presence of plasminogen, sperm binding to the ZP and fertilization in vitro
are enhanced, suggesting that the PA/plasmin system does play a role in
fertilization. However, itis not known whether enhanced fertilization in the
presence of plasminogen is due to the increase in sperm binding to the ZP, or to
enhanced ZP penetration by the sperm, or both (Huarte et al., 1993).
Hatching
Prior to implantation, the mammalian embryo must shed thezona
pellucida, the glycoprotein matrix which surrounds it throughout preimplantation
development. This process, known as hatching, mustoccur in order for the
trophectoderm to make contact with the endometrium during the implantation
process. Mechanical and biochemical systems are hypothesized to be
responsible for the ability of the embryo to hatch. First, expansion of the
blastocoel, the fluid-filled cavity of the early embryo, near the time of hatching
generates mechanical force on the ZP in the form of hydrostaticpressure. This
pressure stretches and thins the ZP, which may result in a weakening of the ZP,
allowing the embryo to rupture the ZP and escape as the blastocoel continuesto
expand (McLaren, 1970; Hurst and MacFarlane, 1981; Coates and Menino,
1994). Second, proteolysis of the ZP may occur, resulting in overallstructural
weakening and facilitating ZP rupture by the expanding blastocoel (Domonet al.,
1973; Perona and Wassarman, 1986).24
It has been proposed that both mechanical and biochemical systems act
in concert to facilitate weakening and rupture of the ZP during hatching
(McLaren, 1970). Proteolytic activity is found in the uterus at the time of hatching
(Surani, 1975). However, the protein content of the ZP does not change as time
of hatching approaches, suggesting that these proteases do not catalyze overall
proteolytic degradation of the ZP (Bergstrom, 1972). [The rabbit is a notable
exception. In rabbits, the embryo does not hatch, but rather the entire ZP is
proteolytically degraded and removed prior to implantation. (Kirchner, 1972)]
Embryos hatch both in vivo and in vitro in the presence of protease inhibitors
(Fazleabas et al., 1983; Coates and Menino, 1994). Also, as the blastocoel
expands, the ZP becomes thin and distorted, suggesting that the mechanical
pressure generated by the embryo is the primary factor responsible for hatching
(Coates and Menino, 1994).
Proteolysis of the ZP during hatching does seem to occur however. While
attempting to develop a more sensitive assay to detect subtle changes in the ZP
during embryonic development, Domon and coworkers (1973) observed
changes in the solubility of the ZP of embryos in the uterus prior to any thinning
or rupture of the ZP. This led the authors to suggest the existence of a zonalytic
agent which catalyzed a "sublysis" of the ZP at the time of hatching. It was
unknown if this zonalytic agent was of uterine or embryonic origin.
Proteases of embryonic origin have been shown to be involved in the
hatching processes of non-mammalian species, including echinoderms (Barret
et al., 1971), amphibians (Carroll and Hedrick, 1974; Urch and Hedrick, 1981),
and teleosts (Schoots, 1981). Proteolytic agents produced by the mammalian
embryo have been suggested to be of importance in implantation, but may also
be of importance for their involvement in the hatching process. Perona and
Wassarman (1986) described a trypsin-like protease in the mouse which was25
associated with cells of the mural trophectoderm. This enzyme, which they
called strypsin, was found to be associated with the ZP following hatching, with
the strongest activity at the opening through which the blastocyst had emerged.
Subsequently, Sawada and coworkers (1990) showed that strypsin is secreted
in increasing amounts over the course of hatching. These authors also showed
that trypsin inhibitors are capable of decreasing the percentage of embryos
hatching, without any adverse effects otherwise on the physiology of the
embryo.
Embryos which are invasive when transplanted to ectopic sites(a
phenomena attributed to embryonic proteases) may be non-invasive in their
normal uterine environment. This coupled with the observation that the uterus
produces inhibitors of serine proteases under the influence of progesterone
(Mullins et al., 1980; Fazleabas et al., 1982) suggests that the embryo has a
specific use for proteolytic enzymes in the hatching process, but that a potent
proteolytic cascade would be harmful to the uterus, and must therfore be
counteracted. Embryos from various species produce PA, which may be
involved in hatching. In the mouse, PA production follows a biphasic pattern,
with PA first detectable at the sixth equivalent gestational day. The trophoblast
produces PA in the first phase and PA production is closely correlated to the
invasive period of the trophoblast. As the parietal endoderm differentiates from
the inner cell mass, it produces PA and is the source of the second phase of PA
activity. The PA produced by the mouse embryo is felt to be involved primarily in
implantation and cell migration (Strickland et al., 1976). In vitro culture ofmouse
embryos in media containing plasminogen or plasmin results in increased
numbers of embryos hatching and attaching to the culture dish compared to26
embryos cultured without plasminogen or plasmin (Menino and O'Claray, 1986).
This suggests that the PA/plasmin system may also play a role in hatching in the
mouse.
In livestock species, PA is produced by embryos from swine (Fazleabas et
al., 1983), cattle (Menino and Williams, 1987), and sheep (Menino et al., 1989).
In swine, the embryo produces PA in a biphasic pattern as well. The first phase
occurs during days 10 to 12 and coincides with the early elongation stages of
embryonic development. The second phase coincides with a marked increase in
the DNA content of the embryo during days 14 to 16. PA production in the first
phase is believed to facilitate cell migration and tissue remodelling in the
elongating blastocyst, whereas in the second phase PA production is associated
with the tissue proliferation which occurs at the filamentous stage of blastocyst
development (Fazleabas et al., 1983).
Plasminogen is present in the uterine environment, presumably asa
serum transudate (Finlay et al., 1983; Fazleabas et al., 1983). Hence, activation
of uterine plasminogen to plasmin could represent a source of proteolytic activity
that may be used in the hatching process. Bovine and ovine embryosare
capable of activating plasminogen to plasmin (Menino and Williams, 1987;
Menino et al., 1989) and produce a urokinase-type PA (u-PA) (Berg and Menino,
1992; Bartlett and Menino, 1993). In vitro culture of bovine embryos in media
containing plasminogen results in accelerated initiation and completion of
hatching as plasminogen concentration increases (Menino and Williams, 1987),
and embryos which produce more total PA are more likelytohatch
(Kaaekuahiwi and Menino, 1990). The trophoblast cells, and not the inner cell
mass, are responsible for the PA produced by the bovine embryo (Dyk and
Menino, 1991). In ovine embryos, PA is produced in increasing amounts during
the morula-to-blastocyst transition and remains high throughout expansion and27
hatching (Menino et al., 1989) The period of PA production and thesource of the
embryonic PA during this period would seem to suggest a role in the hatching
mechanism as opposed to cell migration and tissue remodelling. Also, culture of
ovine embryos in medium containing plasminogen results in increased incidence
of hatching and increased ZP solubilty (Menino et al., 1989).
These results suggest that the PA produced by embryos is capable of
activating plasminogen present in the uterine environment to plasmin. Plasmin
could then catalyze limited proteolysis of the ZP. Also, since PA has been shown
to use substrates other than plasminogen (Keski-Oja and Vaheri, 1982; Baron-
Van Evercooren et al., 1987),it may be that the embryonic PA itself acts
proteolytically on the ZP. Either way, the PA/plasmin system may be the
zonalytic agent responsible for the "sublysis" of the ZP suggested by Domon
and coworkers (1973), which would weaken the ZP glycoprotein matrix and
facilitate hatching.
Implantation
PA may play an active role in the invasion of the trophoblast into the
uterine wall. This event is known as implantation, and inmany species is a
process that involves penetration of the endometrium by cells of the trophoblast.
It has been known for some time that trophoblast cells possess invasive
properties. Trophoblasts transfered to ectopic sites are capable of tissue
invasion. Pathologists have described the trophoblast to be "pseudomalignant"
or "pseudometastatic" in nature, as trophoblast cells can be found in the lungs of
nearly half of all pregnant women. Choriocarcinoma, a pathological condition of28
the trophoblast in which the cells remain invasive throughout and beyond
pregnancy, is one of the most metastatic tumors known (reviewed by Strickland,
1980).
In the mouse, PA secretion is correlated with the period of development
during which the trophoblast is invasive (Strickland et al., 1976). Also, parietal
endoderm cells produce PA as soon as they differentiate from the inner cell
mass, which suggests that PA may facilitate the migration of parietal endoderm
along the trophectodermal surface (Strickland et al., 1976). In situ hybridization
studies demonstrate the presence of u-PA mRNA in the invasive trophoblast
cells of the early mouse embryo. u-PA mRNA was localized to the trophoblast
cells that had migrated into the uterine wall, while trophoblast cells surrounding
the embryo were devoid of u-PA mRNA. By 10.5 days of gestation, when the
trophoblast cells are no longer invasive, u-PA mRNA is undetectable (Sappino et
al., 1989). In a mutant strain of mice termed "implantation-defective", embryos
make poor contact with the uterine wall at the normal time of implantation, and
invasion of the endometrium by the trophoblast does not occur. Trophoblasts of
these embryos produce less PA than normal mice, suggesting that the lack of
invasive capabilityisdirectly correlated to the decreased PA production
(Axelrod, 1985).
Trophoblasts that possess invasive properties also express the u-PA
receptor. Trophoblast cells derived from first trimester human placentae bind
more u-PA than cells isolated from term placentae. Also, syncytiotrophoblast
cells exhibit diminished expression of u-PA receptors and have less u-PA
receptor mRNA compared to cytotrophoblast cells in vitro (Zini et al., 1992).
Receptor-bound u-PA has been shown to be important for implantation using
mutant mice which cannot remove inactivated u-PA from the trophoblast cell
surface. In this model, the low density lipoprotein-related protein (LRP)gene was29
mutated and the effect on implantation was examined. LRP is a clearance
receptor which has been proposed to mediate cellular uptake and degradation
of surface receptor-bound protease-inhibitor complexes (Strickland et al., 1990).
The expression pattern of LRP in the normal post-implantation mouse embryo
parallels u-PA expression. Additionally, in embryos from mutant mice in which
the LRP is non-functional, uptake of u-PA complexed with plasminogen activator
inhibitor-1 (PAI-1) does not occur, and the trophoblast fails to implant (Herz et
al., 1992). These results suggest that inactive u-PA-PAI-1 complexes must be
removed from the invading trophoblast cell surface and replaced with activeu-
PA bound to its' receptor for implantation to occur.
PA may also play an indirect role in implantation. The pig possessesa
non-invasive trophoblast which produces PA at the time of blastocyst elongation
and attachment of the trophoblast to the uterus (Mullins et al., 1980). Similarly,
bovine and ovine embryos produce PA in the period of elongation of the embryo
and attachment (Dyk and Menino, 1991; Bartlett and Menino, 1993). These
species are also known to possess non-invasive trophoblasts. However, it has
recently been shown that embryos from all these species produce secreted and
tissue-associated collagenases during the period of elongation and attachment
(Chamberlin and Menino, 1995; Chamberlin, 1995). It has been hypothesized
that these embryonic collagenases may play a role in attachment of the non-
invasive trophoblasts to the endometrium. Production of collagenases is
associated with invasive periods of development in the human trophoblast
(Shimonovitz et al., 1994). Plasmin is capable of activating pro-collagenase to
collagenase (He et al.1989). Here PA may play an indirect role in implantaion
through the collagenase cascade by activation of plasminogen to plasmin in the
uterine environment.30
STATEMENT OF THE OBJECTIVES
The model system chosen for this research was the bovine. The reasons
for this choice were several. First, the amounts of raw ZP material needed to
carry out the experiments performed in this research were readily obtainable in
sufficient quantities from bovine source material. Second, much of the available
knowledge concerning the mechanisms of interest in this research has been
derived from experiments performed using the bovine model. Thus therewas a
vast body of resources from which to draw information and make conclusions.
Most important however is the direct applicability of the knowledge derived from
this research to the development of improved reproductive technologies foruse
in the cattle production industries. As the demand for higher quality meat
products and genetically superior dairy animals increases, the need for faster
genetic improvment and increased effeiciency of production will also increase.
Techniques such as in vitro fertilization and embryo transfer will become much
more widespread, much as artificial insemination has become common practice
today.Itwilltherefore be necesary to improve the efficiency of these
reproductive technologies to meet these demands. The research described here
is one step further toward that goal.
It is known that addition of plasminogen, the primary substrate for PA, to
culture medium results in increased in vitro fertilization rates (Huarte et al., 1993),
increased hatching rates (Menino and Williams, 1987; Menino et al., 1989), and
increased solubility of embryonic ZP (Menino et al., 1989). Since both male and
fermale gametes and preimplantation embryos are known to produce PA and
are able to activate plasminogen to plasmin (Huarte et al., 1993; Menino et al.,
1987; Menino et al., 1989), it seems plausible that the PA/plasmin systemmay31
act in these processes to bring about proteolytic degradation of the ZP. During
fertilization, the sperm cell can activate plasminogen to plasmin, which could
catalyze localized proteolysis of the ZP, allowing the sperm to penetrate. During
hatching, the embryo can activate plasminogen to plasmin, which could then
catalyze overall proteolytic degradation of the ZP, weakening it and facilitating
its' rupture by the embryo. Because PA is capable of proteolytically degrading
susbstrates other than plasminogen (Keski-Oja and Vaheri, 1982; Baron-Van
Evercooren et al., 1987), it may also be possible that PA itself proteolytically
degrades the ZP. With this in mind, the objectives of the research described
herein were two-fold: first, to determine whether plasmin is capable of proteolytic
degradation of the ZP; and second, whether the PA secreted by the embryo is
capable of proteolytically degrading the ZP.32
EVALUATION OF ALTERATIONS IN THE BOVINE ZONA
PELLUCIDA INDUCED BY PLASMIN OR EMBRYONIC
PLASMINOGEN ACTIVATOR
Abstract
To evaluate the effects of the plasminogen activator/plasmin system on
the zona pellucida (ZP), SDS-PAGE and zona pellucida dissolution time (ZPDT)
assays were conducted on intact ZP isolated from bovine ovarian oocytes
incubated with plasmin or embryonic plasminogen activator. ZP were incubated
with 0 or 100 µg /ml plasmin at 39° C for 0, 24 or 48 h in time course
experiments, or with 0, 100 or 200 µg /ml plasmin for 0 or 24 h in dose-response
experiments. Following incubation, plasmin was removed from ZP by washing in
PBS containing 0.1% polyvinylpyrrolidone and 0.02% polyethylenesorbitan
monooleate, and were dissolved in SDS-PAGE sample buffer containing 13-
mercaptoethanol andelectrophoresis was performedin10% or 12%
polyacrylamide gels. Electrophoretic profiles of the ZP polypeptides were divided
into six molecular weight (MW) classes (>100,000, 75,000-100,000, 60,000-
75,000,26,000-60,000,20,000-26,000and<20,000)andevaluated
densitometrically. ZPDT assays were conducted and plasmin activities were
measured during the incubation period.
SDS-PAGE of the bovine oocyte ZP resultedinresolution of two
polypeptides with MW 76,000 and 65,000,respectively, and two minor
polypeptides with MW 23,000 and 22,000 that migrated as a doublet. No
changes occurred in any MW classes in ZP incubated with 0 1.1g/m1 plasmin for33
0, 24 or 48 h, and ZPDT were not different (P>0.10). ZP treated with 100µg /ml
plasmin exhibited decreases in the MW >100,000 and 20,000-26,000 classesat
24 and 48 hcompared to 0 µg /ml. ZPDT were lower (P<0.05) at 24 and 48 h in
100 p.g/ml, and plasmin activities were decreased at 24 and 48 h (P<0.05).
Bovine ZP treated with 100 or 200 pg/mIplasmin exhibiteda decrease (P<
0.10) in the polypeptides in the MW >100,000 class in 200µg /ml, and increases
(P<0.10) in the MW 26,000-60,000 and <20,000 classes in 100 and 200µg /ml
compared to 0 pg/m1plasmin at 24 h. ZPDT were lower (P<0.05) in 100or 200
g/ml compared to 0 µg /ml plasmin at 24 h. ZPDT were also lower (P4.05) for
ZP treated with 200 µg /ml plasmin compared to 100 µg /ml plasmin. Activity of
both plasmin concentrations was decreased at 24 h (P4.05).
Inbovine ZP treatedwith50µg /mlactiveor4-(2-aminoethyl)
benzenesulfonyffluoride-inactivated plasmin at 39° C for 0, 24 or 48 h, decreases
in the MW >100,000 and 75,000-100,000 and increases in the 60,000-76,000 MW
class occurred at 24 and 48 h in active plasmin. ZP solubility was increased at 24
and 48 h in active plasmin. Compared to 0 µg /ml plasmin, ZPDTwere lower (P<
0.05) at 24 and 48 h in inactivated and active plasmin. Caseinolytic activity of
active plasmin was lower (P<0.05) at 48 h compared to 0 and 24 h. Activity of
inactivated plasmin was lower (P<0.05) at 0, 24 and 48 h compared to active
plasmin, but activity of inactivated plasmin increased (P4.05) at 24 and 48 h.
ZP were also treated with embryonic plasminogen activator. Day 7
embryos(dayofestrus= Day0)werecollectednon-surgicallyfrom
superovulated cows and cultured in Ham's F-12+ 1.5% BSA at 39° C in 5% CO2
in air and conditioned medium was collected every 48 h and pooled. Embryo-
conditioned medium used to treat ZP contained plasminogen activating activity
equal to approximately 33 IU/m1 human urokinase. ZP treated withnon-
conditioned or embryo-conditioned medium for 0 or 48 h at 39° C exhibitedno34
changes in ZP polypeptide MW classes (P>0.10). ZPDT were not different
between non-conditioned and embryo-conditioned medium at 0 and 48 h (P>
0.10). Addition of human plasminogen (100 µg /ml) to embryo-conditioned
medium resulted in a decrease (P<0.10) in the MW 75,000-100,000 class andan
increase in the <20,000 class at 48 h. These results demonstrate thatbovine
plasminis capable of proteolytically degrading the bovine ZP, and that
embryonic plasminogen activator is capable of activating plasminogen in the
presence of the ZP, thereby indirectly affecting the ZP through activation of
plasminogen to plasmin. Changes in the specific MW classes anddecreases in
ZPDT suggest that the plasminogen activator/plasmin system couldexert
proteolytic effects on the ZP during fertilization and hatching.
Introduction
In mammalian species, the female gamete, the oocyte, is surroundedby
an acellular glycoprotein matrix, the zona pellucida (ZP), at the time of ovulation.
The ZP is composed of multiple glycoprotein components (Wassarman,1988)
that are products of developmentally related genes (Dean, 1991)and that
display antigenic cross-reactivity (Maresh and Dunbar, 1987) andbiochemical
similarities (Wassarman, 1988) across species. The ZPserves a number of
important rolesin early embryonic development: the ZP containssperm
receptors (Wassarman, 1988; Sacco et al., 1989), and contact withthe ZP
induces the acrosome reaction in capacitated sperm (Wassarman,1988;
Florman and First, 1988). The ZP undergoes a process knownas "zona
hardening" following fertilization, thus forming a block to polyspermy(Hoodbhoy35
and Talbot, 1994). The ZP also is essential for maintaining the physical integrity
of the early embryo up to the fully-compacted late-morula stage (Betteridge and
Flechon, 1988). At some point however, the ZP must be shed in order for the
embryo to contact the endometrium at implantation.
Plasminogen activators (PA) are serine proteases capable of converting
the zymogen plasminogen to the active serine protease plasmin. There are two
main types of PA found in mammalian species: tissue-type PA (t-PA) and
urokinase-type PA (u-PA) (Dano et al., 1985). The primary physiological role of t-
PA is felt to be conversion of plasminogen to plasmin in the circulation during
lysis of fibrin clots, while the primary role of u-PA is felt to be conversion of
plasminogen to plasmin in the tissues during extracellular matrix degradation
and cell migration (Dano et al., 1985; Saksela and Rifkin, 1988). PA are also
known to be involvedin a number of reproductive processes, such as
spermatogenesis (Vihko et al., 1988; Tolli et al., 1995), and ovulation (Reich et
al.,1985; Somokovitis et al.,1988), and are suspected to be involved in
fertilization(Huarte etal.,1993), hatching (Menino and O'Claray, 1986;
Kaaekuahiwi and Menino, 1990) and implantation (Axelrod, 1985; Sappino et al.,
1989).
Recently it has been demonstrated that transgenic mice in which the
acrosin gene is made non-functional are still fertile (Baba et al., 1994). In vitro
fertilization shows that sperm from the transgenic mice will penetrate the ZP,
albeit slower than sperm from normal mice (Baba et al., 1994). It has been
demontrated that both murine gametes posses PA activity. Ovulated oocytes
produce t-PA (Huarte etal.,1985) and ejaculated spermatozoa posses
recepetors for u-PA and exhibit u-PA activity (Huarte et al., 1987). Both gametes
are capable of activating plasminogen to plasmin, and addition of plasminogen
to in vitro fertilization media enhances sperm binding to the ZP and fertilization36
(Huarte et al., 1993). However, it is not known whether increased fertilization
rates in the presence of plasminogen are due to the increase in sperm binding to
the ZP, or to enhanced penetration of the ZP by sperm, or both (Huarte et al.,
1993).
During hatching, it has been hypothesized that two forces work in concert
to facilitate the rupture of the ZP: mechanical force in the form of hydrostatic
pressure from the expanding blastocoel, and proteolytic weakening or "sublysis"
of the ZP (McLaren, 1970; Domon et al., 1973; Perona and Wassarman, 1986). It
has been suggested that the mechanical force of the expanding embryo is the
major force responsible for rupture of the ZP (Coates and Menino, 1994), but
proteolytic activity is found associated with the ZP of hatched embryos, most
notably at the site of ZP rupture (Perona and Wassarman, 1986).
Plasminogen is known to be present in the uterine environment (Finlay et
al., 1983; Fazleabas et al., 1983). PA is secreted by murine (Strickland et al.,
1976), porcine (Fazleabas et al., 1983), ovine (Menino et al., 1989) and bovine
(Menino and Williams, 1987) embryos. Bovine and ovine embryos produce au-
PA (Berg and Menino, 1992; Bartlett and Menino, 1993) and are capable of
activating plasminogen to plasmin (Menino and Williams, 1987; Menino et al.,
1989). In vitro culture of bovine embryos in media containing plasminogen
results in accelerated initiation and completion of hatching (Menino and Williams,
1987) and embryos which produce more total PA are more likely to hatch
(Kaaekuahiwi and Menino, 1990). This suggests that the PA/plasmin system
may be able to catalyze a proteolytic weakening or "sublysis" of the ZP, as
observed by Domon and coworkers (1973), at the time of hatching.
The objectives of this research were two-fold: first to determine if bovine
plasmin is capable of altering the character of the bovine ZP. Also, since PA has
been shown to act on substrates other than plasminogen (Keski-Oja and Vaheri,37
1982; Baron-Van Evercooren et al., 1987), the second objective of this research
was to examine the possibiltiy that bovine embryonic PA could alter the
character of the bovine ZP.
Materials and Methods
Collection of Oocytes and Isolation
of Zonae Pellucidae
Bovine ovaries were collected from animals at slaugter and stored at -20°
C prior to isolation of oocytes. To isolate ZP-bound oocytes from ovarian
follicles, batches of ovaries were macerated in 250-300 ml of 0.9% NaCI usinga
blender. Prior to maceration, large follicles were punctured and drained of
follicular fluid, and all corpora lutea were removed. The maceration extractwas
strained through cheese cloth to remove large debris, and poured througha
teflon filter screen with a grid size of 72 iim. All undisrupted ovarian tissuewas
returned to the blender. This procedure was repeated three to four times until all
ovarian tissue was thoroughly disrupted. The teflon filterscreen was then
inverted over a glass collection dish, and the screen was sprayed with 60 ml of
phosphate buffered saline containing 0.1% polyvinylpyrrolidone and0.02%
polyethylenesorbitan monooleate (PBS/PVP/Tween) to wash oocytes into the
dish. Collection dishes were then searched using a dissecting microscopeat
10x magnification, and oocytes were removed by aspiration witha small glass38
micropipette and placed in fresh PBS/PVP/Tween. ZP-bound oocyteswere
stored in PBS/PVP/Tween at 4° C until ZP isolation.
To remove and isolate ZP, oocytes were placed in PBS/PVP/Tween ina
1.5 ml microcentrifuge tube and centrifuged at 14,000x gravity forone minute to
pellet oocytes. All but a minimal volume of mediawas then removed, and
oocytes were cracked using a teflon micropestle fitted to the microcentrifuge
tube. One hundred microliters of PBS/PVP/Tweenwas added and oocytes
were vortexed for four to five minutes to remove the vitellus and any adherent
cumulus cells from the ZP. Oocytes and isolated ZP were then removed from the
microcentrifuge tube and placed in PBS/PVP/Tween in a 60x15mm Falcon petri
dish, and isolated ZP were separated from uncracked oocytes. This procedure
was repeated until no oocytes remained uncracked. Isolated ZP were aliquoted
into microcentrifuge tubes, 250 ZP per tube, and storedat -20° C in
PBS/PVP/Tween until use in experiments.
Enzymes and Inhibitors
Bovine plasmin (EC 3.4.21.7 (Sigma)) used to treat ZPwas prepared in
phosphate buffered saline (PBS) at a concentration of 1 mg/ml, andstored in
500-0 aliquots at -20° C. Plasmin was then diluted to concentrationsof 200 or
400 gg/mlwith PBS, and stored in 5011.1aliquots at -20° C untiluse.
4-( 2- Aminoethyl )benzensulfonylfluoride (AEBSF (Sigma))was used to
inhibit plasmin. AEBSF was dissolved in PBS containing 0.05%sodium azide
(PBS+ .05% NaN3), and stored at -20° C in 100-0 aliqouts ata concentration of
10mg/m1 prior to use.39
Medium containing bovine embryonic plasminogen activator was removed
from bovine embryos in culture. Bovine blastocysts at gestational Day 7 were
recovered non-surgically from super-ovulated cows. Cows were administered
two 25 mg injections i.m. of prostaglandin Fla (Lutalyse) 12 days apart (day of
first injection = Day 0), and a 24 mg or 36 mg injection series i.m. of porcine
follicle stimulating hormone over four days beginning on day 10. Animals were
monitored for signs of estrus and were either artificially inseminated at 0, 12 and
24 h after onset of estrus or were mated by natural service for as long as the
cow would accept the bull. Embryos were non-surgically recovered using PBS
containing 1% antibiotic/antimycotic (Sigma) and 0.2% heat treated cow serum.
Embryos were recovered from the flushings and cultured in 50-0 microdrops of
Ham's F-12 containing 1.5% bovine serum albumin (BSA) under light paraffin oil
at 39° C in 5% CO2 in air. Embryos were moved every 48 h to fresh microdrops
alternating between concentrations of 1.5% and 0.15% BSA in culture medium.
Embryo-conditioned medium was removed from culture dishes immediately
following removal of embryos and stored at -20° C until use.
Urokinase (UK) (EC 3.4.21.73) from American Diagnostica was used as
the standard for calculation of plasminogen activator activity in the embryo
media pool. UK was prepared in PBS and stored at concentrations of 100 IU/m1
at -20° C untiluse. Human plasminogen (hPgn) from Sigma usedin
determination of plasminogen activator activity in the embryo media pool was
prepared in PBS and stored at concentrations of 1.2 mg/ml at -20° C until use.
Determination of the plasminogen activator activity in embryo-conditioned
media was performed using a caseinolytic plate assay with UK as the standard.
UK at concentrations of 100, 50, 10, 5, 1, .5 and 0 IU/m1 were made by diluting
100 IU/m1 UK stock solution in PBS+ .05% NaN3. Forty-five microliters of UK
standards or embryo media pool were combined with 45 1.11 of 120 µg /ml hPgn,40
and 25 III of this mixture were then pipetted into wells in caseinolyticassay plates
for determination of PA activity. The caseinolyticassay plates for determination
of PA activity were prepared as follows: 4% dried skim milkwas dissolved in Tris-
glycine caseinolytic buffer at 65° C. To thiswas added an equal volume of 2%
melted agarose and 15 ml of this mixture was pipetted into caseinolyticassay
plates. After the casein-agar gel solidified, 4 mm wellswere punched into the
substrate, and the wells were cleared using a glass pipette connectedto a
vacuum. All samples were pipetted in triplicate. Also, to examine for non-specific
protease activity, embryo media pool was combined with 0µg /ml hPgn, and
samples were pipetted into wells in the caseinolyticassay plates. Plates were
then incubated at room temperature for 24 hours, and fixed with 3%acetic acid.
Lytic zones in the plate were measured with a digital calipers, and thediameters
recorded. Correlation-regression analysis was used to determinethe PA
activities in the embryo media pool from plots of lytic ring diametersversus log
urokinase concentrations.
Peptide Mapping of ZP Treated with Plasmin
or Embryo Plasminogen Activator
Time Course and Dose-response with Bovine Plasmin
Isolated ZP were exposed to bovine plasmin at concentrationsof 0 or 100
pg /ml for 0, 24 or 48 h in time course experiments or 0, 100or 200 µg /ml for 0
or 24 h in dose-response experiments. Prior to treatment, ZPwere thawed and
washed three times in their sample tubes with 1 ml of PBSto remove PVP and41
Tween present in the PBS/PVP/Tween in which ZP were originally stored. ZP
were centrifuged at 14,000x gravity and all but 50 d of PBS was removed from
sample tubes. Tubes were examined under a dissecting microscope to affirm
that ZP were still present in the sample tubes. Fifty microliters of bovine plasmin
at concentrations of 0 or 200 µg /ml in time course experiments and 0, 200 or
400 µg /ml in dose-response experiments were added to individual sample
tubes, for final concentrations of 0 or 1001.1g/m1 and 0, 100 or 200µg /ml bovine
plasmin respectively. Samples were allowed to incubate at 39° C for 0, 24or 48
h for time course or 0 or 24 h for dose-response experiments. Following
incubation, intact ZP were washed with 1 ml of PBS/PVP/Tween, centrifuged at
14,000x gravity, and all but 100 pl of PBS/PVP/Tweenwas removed. This
procedure was repeated a total of five times to completely remove plasmin.
Time Course with Inactivated and Active Plasmin
Isolated intact ZP were exposed to inactivated or fully active plasmin for 0,
24 or 48 h. Prior to treatment, ZP were thawed and washed three times in their
sample tubes with 1 ml of PBS to remove PVP and Tween. ZPwere centrifuged
at 14,000x gravity, and all but 50 0 of PBS was removed from sample tubes.
Fifty microliters of active or inactivated plasmin was then addedto individual
sample tubes, and samples were allowed to incubate for 0, 24or 48 h at 39° C.
To inactivate plasmin samples, 50 pi of 10 mg/ml AEBSF in PBS+.05% NaN3
was added to 50 pl of bovine plasmin at an initial concentration of 200 pg/ml,
and this mixture was allowed to incubate at 39° C for 90 minutesto allow full
active site titration and inactivation of plasmin. Fully active plasminwas prepared42
by addition of 50plPBS+.05%NaN3 to 50 pl of 200 µg /ml bovine plasmin, and
this mixture was also incubated for 90 minutes at 39° C. Following this
incubation period, 50 pl of inactivated or active plasmin was added to ZP
aliquots, for a final concentration in the reaction mixture of 50 µg /ml inactivated
or active plasmin. Following incubation, the intact ZP were washed with 1 ml of
PBS/PVP/Tween, centrifugedat 14,000x gravity, andallbut 100 plof
PBS/PVP/Tween was removed. This procedure was repeated a total of five
times to completely remove plasmin.
Time Course with Embryonic Plasminogen Activator
ZP were exposed to non-conditioned culture medium or embryo-
conditioned medium for 0 or 48 h. Prior to treatment, ZP were thawed and
washed three times in their sample tubes with 1 ml of PBS to remove PVP and
Tween. ZP were centrifuged at 14,000x gravity, and all but 50plof PBS was
removed from sample tubes. Fifty microliters of non-conditioned mediumor
embryo-conditioned medium was then added to individual sample tubes, and
samples were allowed to incubate for 0 or 48 h. Following incubation, intact ZP
were washed with 1 ml of PBS/PVP/Tween, centrifuged at 14,000x gravity, and
all but 100 pl of PBS/PVP/Tween was removed. This procedure was repeateda
total of five times to completely remove plasminogen activator and culture
medium constituents.
Following removal of enzyme preparations or culture media from ZP,
aliquotswerecentifugedat14,000xgravityandallbut100 p.1of
PBS/PVP/Tween were removed from sample tubes. One hundred microliters of43
2x SDS-PAGE sample buffer containing P-mercaptoethanol was then added to
ZP aliquots, and the mixture boiled for four minutes. Samples were loaded onto
wells of a 4% stacking gel, and electrophoresis was performed on either 10%or
12% SDS-PAGE gels.
Following electrophoresis of ZP samples, gels were fixed in 5:5:1:.25
methanol:water:acetic acid:glycerol for 30 minutes, followed byan overnight
soak in 50% methanol. After soaking in methanol, gelswere stained using the
silver staining technique described by Wray and coworkers (1981) modified for
12mmx15mm acrylamide slab gels. Gels were allowed to stain until bandswere
sufficiently dark and the gel began to take on a yellowappearance.
Development was stopped by placing gels in 10% acetic acid.
After staining, gels were soaked in 50% methanol overnight and dried
using a Hoefer Scientific Drygel Jr. vacuum gel dryer. Dried gelswere then
scanned using a Hoefer GS350H Scanning-Computing Densitometer.
Calcualtion of Molecular Weights and Relative Percents
of ZP Polypeptide Molecular Weight Classes
Molecular weights of the major ZP bandswere calculated using the
molecular weight functionof theHoefer GS350H Scanning-Computing
Densitometer software, with Bio-Rad low-range standardsas molecular weight
standards.44
Polypeptide profiles of the ZP were separated into six classes basedon
the staining patterns of the major bands: MW >100,000, 75,000-100,000 60,000-
75,000, 26,000-60,000, 20,000-26,000, and <20,000. Relative percents of each
class for each treatment in each gel were determined using the review and
integrate functions of the Hoefer GS350H Scanning-Computing Densitometer
software.
Zona Pellucida Dissolution Time and Plsmin
Activity Assays
ZPDT Time Course and Dose-response
ZP were exposed toeither bovine plasmin or bovine embryonic
plasminogen activator in treatments mimicking those performedon ZP for
peptide mapping experiments, and zona pellucida dissolution time (ZPDT) in
0.2% SDS was recorded.
Fifty microliter aliqouts of bovine plasmin at 0 and 200 gg/m1 for time
course or 0, 200 or 400 jig/mlfor dose-response were thawed and diluted with
50 111 of PBS+ .05% NaN3 to final concentrations of 0 and 100µg /ml for time
course experiments or 0, 100 or 2004/mlfor dose-response experiments. Ten
microliter drops of plasmin at each concentrationwere pipetted into 60x15mm
Falcon petri dishes, and covered with paraffin oil. Five intact ZPwere added to
each drop in a minimal volume of PBS, and plates containingtreatment drops
were incubated at 39° C for 0, 24 or 48 h for time course or 0 or 24 hours for
dose-response. Each treatment was replicated three times for each time point.45
Following treatments, ZP were removed from treatment drops and washed
in PBS/PVP/Tween to remove plasmin. Washed ZP were then pipetted in 5 pl of
PBS/PVP/Tween into a 50 pl drop of 0.2% SDS on a concave microscope slide.
ZP were then monitored under an inverted stage phase-contrast microscope at
100x magnification and dissolution times were recorded.
ZPDT Time Course with Inactivated and Active Plasmin
Inactivated and active plasmin samples prepared as described earlier
were diluted with 100 pl of PBS+ .05% NaN3 to a final concentration of 50 µg /ml.
10 i_d drops of inactivated or active plasmin were pipetted into 60x15mm Falcon
petri dishes, and covered with paraffin oil. Five intact ZP were added to each
drop in a minimal volume of PBS, and plates containing treatment dropswere
incubated at 39° C for 0, 24 or 48 h. Each treatment was replicated three times
for each time point.
Following treatments, ZP were removed from treatment drops and washed
in PBS/PVP/Tween to remove plasmin. Washed ZP were then pipetted in 5 pl of
PBS/PVP/Tween into a 50 pl drop of 0.2% SDS on a concave microscope slide.
ZP were then monitored under an inverted stage phase-contrast microscope,
and dissolution times were recorded.46
ZPDT Time Course with Embryonic Plasminogen Activator
10 pl drops of either non-conditioned culture medium or embryo-
conditioned culture medium were pipetted into 60x15mm Falcon petri dishes,
and the drops were covered with paraffin oil. Five intact ZP were added to each
drop in a minimal volume of PBS, and plates containing treatment drops were
incubated at 39° C for 0 or 48 h. Each treatment was replicated three times for
each time point.
Following treatments, ZP were removed from treatment drops and washed
in PBS/PVP/Tween to remove plasmin. Washed ZP were then pipetted in 5 pl of
PBS/PVP/Tween into a 50 pi drop of 0.2% SDS on a concave microscope slide.
ZP were then monitored under an inverted stage phase-contrast microscope,
and dissolution times were recorded.
PlasminActivity Assays
In addition to 10 pl drops containing ZP for ZPDT assays, 10 pl drops
without ZP were also incubated in parallel in all plasmin ZPDT assays toassess
the activity of plasmin over the incubation period. Plasmin activity drops were
pipetted out of the plates following ZPDT assays, pooled, and activitywas
measured using the caseinolytic plate assay, as previously described. Activity
was described on the basis of enzyme units, one enzyme unit being equal to
one mm in the diameter of the lytic rings in the assay plate. Correlation-
regression analysis was also used to determine the activity of inactivated
plasmin from plots oflyticring diameters versus log plasmin standard47
Statistical Analysis
Differences in the relative percents of the major MW classes comprising
the polypeptide profiles due to treatment were determined using Chi-Square
analysis. Differences in ZPDT and plasmin activities were determined usingone-
way analysis of variance, and differences between specific means were identified
using Fisher's least significant differences procedures.
Results
SDS-PAGE of bovine ovarian oocyte ZP under reducing conditions
revealed two major polypeptides with approximate MW of 65,000 and 76,000
and two minor polypeptides that migrated as a doublet with approximate MW
22,000 and 23,000 (Figure I a). The MW 65,000 and 76,000 polypeptides
accounted for approximately 26% and 13 % of the densitometerscan
respectively, whereas the MW 22,000 and 23,000 polypeptidescollectively
comprised 21%.48
Figure 1:SDS-PAGE and densitometric scans of 250 bovineoocyte zonae
pellucidae treated with 01..tg/mIplasmin for a) 0, b) 24or c)48 h at 39° C.
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Time Course with Plasmin
ZP were treated with 01.1g/m1plasmin for 0, 24 or 48 h at 39° C to examine
the possibilty that autolysis of the ZP may be occurring during incubation. ZP
treated with 0 µg /ml plasmin for 0, 24 or 48 h exhibited no changes in the six
polypeptide classes (P>0.10) (Figures la, b and c). ZP solubility in 0.2% SDS
also did not differ (P>0.10) following incubation for 0, 24 or 48 h, suggesting that
no spontaneous autolysis of the ZP was occurring (Figures 2a, b, c, and d, and
Figure 3a.).
Bovine ZP treated with 100 pg/m1plasmin for 24 or 48 h at 39° C exhibited
decreases (P<0.10) in the MW >100,000 class at 24 and 48 h compared to 0 h
(Figures 4a, b and c). At 0 h in 100 1.1g/m1 plasmin, a slight decrease in staining
intensity was observed in the MW 23,000 and 22,000 doublet compared to 0 .t
g/ml plasmin. Decreases in the MW 20,000-26,000 classes occurred in 100 11
g /ml plasmin at 24 and 48 h compared to 100 gg/m1 at 0 h. At 24 and 48 h in
100 gg/m1 plasmin, the staining intensity of the MW 76,000 band decreased and
the MW 22,000 and 23,000 doublet disappeared(Figures 4b andc).
Appearance of a diffuse band of approximate MW 45,000 to 50,000 was also
observed (Figures 4b and c).
Solubility of ZP treated with 100 µg /ml plasmin increased at 24 and 48 h of
incubation. Compared to 0 µg /ml plasmin, ZPDT were lower at 24 and 48 h in
100 µg /ml plasmin (P<0.05) (Figure 3a). Plasmin activities decreased over time
inculture. Compared to 0 h, plasmin activityin the 100 µg /ml plasmin
preparation declined at 24 and 48 h (P<0.05) (Figure 3b).50
Figure 2: Bovine oocyte zonae pellucidae treated with 0 4g/m1plasmin for 0 h at
39° C during zona pellucida dissolution time (ZPDT)assay at a) 0, b) 5 and c) 10
minutes and d) at dissolution (200X).51
Figure 3:(a) Zona pellucida dissolution times (ZPDT)for ZP treated with 0 or
100 µg /ml plasmin for 0, 24 and 48 h, and (b)recovered plasmin activities at 0,
24 or 48 h. Values withoutcommon superscripts are different (P<0.05).
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Figure 4:SDS-PAGE and densitometric scans of 250 bovine oocytezonae
pellucidae treated with 100 iig/mIplasmin for a) 0, b) 24or c)48 h at 39° C.
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Dose-response with Plasmin
Bovine ZP treated with 100 or 200 pg/m1 plasmin for 0 h at 39° C exhibited
a slight increase in staining intensity of the MW <20,000 polypeptide class
relative to 0 pg/m1 plasmin (Figures 5a, b and c). Polypeptides in the MW >
100,000 class in 200 µg /ml decreased compared to 0 or 100 14/m1 at 24 h (P<
0.10) (Figures 6a, b and c). Relative percents of polypeptides in the MW 26,000-
60,000 and <20,000 classes in 100 and 200 pg/mIplasmin at 24 h increased (P<
0.05) whereas polypeptides in the MW 20,000-26,000 classes decreased (P<
0.10). Treatment with 100 or 200 pig/m1 plasmin decreased the staining intensity
of the MW 76,000 polypeptide and often caused the disappearance of the MW
22,000 and 23,000 doublet. However, this treatment often caused the
appearance of a diffuse band with approximate MW of 45,000-50,000 and a low
MW polypeptide of MW <10,000 (Figures 6b and c).
Solubility of ZP treated with 100 or 200 µg /ml plasmin for 24 h increased
relative to 0 1.1g/m1 plasmin. ZPDT of ZP treated with 100 or 200 1.1g/m1 plasmin
were lower (P<0.05) at 24 h of incubation compared to 0 1.1g/m1 plasmin (Figure
7a). ZPDT were also lower (P<0.05) for ZP treated with 200 µg /ml plasmin
compared to 100 µg /ml plasmin. Plasmin activities decreased (P<0.05) during
the incubation (Figure 7b). Compared with activity at 0 h, both concentrations of
plasmin showed reduced activity at 24 h (P<0.05).54
Figure 5:SDS-PAGE and densitometric scans of 250 bovineoocyte zonae
pellucidae treated with a) 0, b) 100 or c) 200µg /ml plasmin for 0 h at 39° C.
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Figure 6:SDS-PAGE and densitometric scans of 250 bovine oocytezonae
pellucidae treated with a) 0, b) 100 or c) 200 lig/mIplasmin for 24 hat 39° C.
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Figure 7: (a) Zona pellucida dissolution times (ZPDT)for ZP treated with 0, 100
or 200 pig/mIplasmin for 0 or 24 h, and (b) recovered plasmin activities at 0or
24 h. Values withoutcommon superscripts are different (P<0.05).
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Time Course with Inactivated and Active Plasmin
Bovine ZP treated with active plasmin at 39° C for 0, 24 or 48 h (Figures
8a, b, and c) exhibited decreases in the MW >100,000 and 75,000-100,000
classes and increases in the MW 60,000-75,000 class at 24 and 48 h compared
to inactivated plasmin (Figures 9a, b, and c). In active plasmin at 24 and 48 h,
the MW 22,000 and 23,000 doublet routinely disappeared (Figures 8b and c).
Also, in the inactivated plasmin at 24 h, the staining intensity of the doublet was
decreased similar to that observed in active plasmin samples at 0 hours.
Staining intensity of the doublet was further reduced at 48 h in inactivated
plasmin.
Solubilty of ZP treated with active plasmin for 0, 24 or 48 h was increased
at 24 and 48 h of incubation (Figure 10a). Compared to inactivated plasmin,
ZPDT were lower at 24 and 48 h in active plasmin (P<0.05). Solubility of ZP
treated with inactivated or active plasmin was increased at 24 and 48 h.
Compared to 0 lag/m1 plasmin, ZPDT were lower (P<0.05) at 24 and 48 h in
inactivated and active plasmin. ZPDT were greater (P<0.05) in 0 µg/m1 plasmin
at 48 h compared to 0 and 24 h. Caseinolytic activity of active plasmin was lower
(P<0.05) at 48 h compared with 0 and 24 h (Figure 10b). Activity of inactive
plasmin was lower (P<0.05) at 0, 24 and 48 h compared to active plasmin.
However, inactivated plasmin did regain some activity at 24 and 48 h of
incubation. Compared to inactivated plasmin at 0 h,activity of inactivated
plasmin increased at 24 and 48 h of incubation to 15 to 20 percent of the activity
of active plasmin at 0 h (Figure 10b).58
Figure 8:SDS-PAGE and densitometric scans of 250 bovine oocyte zonae
pellucidae treated with 50 4g/mlactive plasmin for a) 0, b) 24 or c) 48 h at 39° C.
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Figure 9:SDS-PAGE and densitometric scans of 250 bovine oocytezonae
pellucidae treated with 50 ggimi AEBSF-inactivated plasmin for a) 0, b) 24or c)
48 h at 39° C.
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Figure 10:(a) Zona pellucida dissolution times (ZPDT) for ZP treatedwith
inactivated (50 tagjml+AEBSF) or active (50 p.g/ml-AEBSF)plasmin for 0, 24 or
48 h, and (b) recovered plasmin activities expressedas percent of active
plasmin at 0 h. Values withoutcommon superscripts are different (P<0.05).
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Time Course with Embryonic Plasminogen Activator
Bovine ZP treated with non-conditioned medium or embryo-conditioned
medium for 0 or 48 h exhibited no changes (P>0.10) in ZP polypeptide MW
classes (Figures 11a, b, c and d). However, when human plasminogen was
added to embryo-conditioned medium (embryo-conditioned medium+ hPgn)
prior to treatment of ZP, changes similar to treatment of ZP with 100 µg /ml
plasmin were observed (Figures 12a, b, c, and d). Relative percents of the
polypeptides were less (P<0.05) in the MW 75,000-100,000 class after 48 h of
incubation in embryo-conditioned medium+ hPgn compared to non-conditioned
medium or embryo conditioned medium. Relative percents of polypeptides in
the MW <20,000 class were greater in embryo-conditioned medium+ hPgn at 48
h of incubation compared to either embryo-conditioned medium+ hPgn at 0 h (P
<0.10), non-conditioned medium and embryo-conditioned medium at 48 h (P<
0.10). Embryo-conditioned medium at 0 h contained plasminogen activating
activity equal to approximately 33 IU/m1 UK. Non-specific caseinolytic proteases
were not detected in embryo-conditioned medium.
ZPDT were lower (P<0.05) at 48 h in both non-conditioned and embryo-
conditioned medium compared to 0 h. However, no differences (P>0.10) in
ZPDT were observedbetweennon-conditionedmedium and embryo
conditioned medium at either 0 or 48 hours (Figure 13).62
Figure 11: SDS-PAGE and densitometricscans of 250 bovine oocyte zonae
pellucidae treated with non-conditioned medium for a) 0and c) 48 h or embryo-
conditioned medium for b) 0 and d) 48 h at 39° C.
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Figure 12: SDS-PAGE and densitometric scans of 250 bovineoocyte zonae
pellucidae treated with embryo-conditioned medium containing 0µg /ml human
plasminogen for a) 0 and c) 48 h or 100 11g/rill human plasminogen for b)0 and
d) 48 h at 39° C.
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Figure 13: Zona pellucida dissolution times (ZPDT) for ZP treated with non-
conditioned or embryo-conditioned medium for 0 or 48 h. Values without
common superscripts are different (P<0.05).
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Discussion
SDS-PAGE of bovine ZP in these experiments resulted in the resolution of
two major bands with MW approximately 76,000 and 65,000, and two minor
bands with MW 23,000 and 22,000. These results differ somewhat from those of
Florman and First (1988), who observed three high MW polypeptides with MW of
94,000-110,000, 82,000-94,000, and 70,000-76,000. Gwatkin and coworkers
(1980) have also electrophoretically analyzed the bovine ZP, and observedthree
bands with MW of 100,000, 50,000 and 25,000. These differencescannot be
explained with certainty, but they may be the result of differences inisolation
procedures or treatment of ZP in preparation for electrophoresis.
The results of plasmin treatment of ZP indicate that plasmin is capable of
proteolytically degrading the ZP. ZP treated with physiological concentrationsof
plasmin (100 µg /ml) for 24 or 48 h show definite alterations in themajor
polypeptide bands present on SDS-PAGE gels when compared with ZP
incubated with 0 µg /ml plasmin. Furthermore, treatment of ZP with200 µg /m1
plasmin for 24 h results in alterations of the major polypeptide bandssimilar to
that seen in the presence of 100 µg /ml plasmin, however the effectis much
more pronounced. The polypeptides most susceptible to proteolytic degradation
by plasmin seem to be the MW 76,000 major polypeptide, and theMW 22,000
and 23,000 minor doublet. Appearance of a diffuse band withapproximate MW
45,000-50,000 presumably reflects a degradation product ofthe MW 76,000
component, which seems to be the more susceptible of thetwo high MW
polypeptides to plasmin degradation.
Changes in the relative percents of the six molecular weightclasses which
the ZP polypeptide profiles were separated into for theseexperiments were
difficult to quantify between gels. This was not the result ofinconsistency of66
polypeptide profiles between gels, but rather was directly the result of the silver
staining technique. Bands developed with varying intensity between gels, and
background development between gels varied greatly. Also, on 10% acrylamide
gels, separation of the high MW bands was not as clear, and the bands could
not be resolved as two separate polypeptides due to the intensity and overlap of
the stain. Consequently, all analyses of changes in polypeptide MWclasses
were performed on 12% acrylamide gels, due to more consistent staining
patterns and better resolution of band separation.
Inactivation of plasmin by AEBSF seems to inhibit most of the effects of
the protease on the MW 76,000 band, howeversome effects are still seen on the
MW 22,000 and 23,000 doublet. This doubletseems to be particularly
susceptible to the proteolytic action of plasmin. In samples treated with 100or
200 µg /ml plasmin for 0 h, the doublet begins to show signs of degradation.In
treatment of 0 h ZP samples, plasmin aliquots were added to the sample tubes,
and then quickly diluted with 1 ml of PBS/PVP/Tween to washout the plasmin. It
may be that the time it takes to completely remove the enzyme from the ZP is
sufficient for plasmin to act on the MW 22,000 and 23,000 doubletto the extent
that the effects are visible in the 0 h plasmin treatments. Sinceinactivated
plasmin gains some of its' proteolytic activity back at 24 and 48 h, itis most likely
that the restored level of activity is sufficient to alter the MW 22,000and 23,000
doublet.
The biochemical alteration of the ZP by plasmin has alsobeen shown to
havephysiologicalsignificance.The zonapellucidadissolutionassays
conducted in these experiments demonstrate that the proteolyticalteration of the
ZP polypepetides results in increased solubility of the ZP. Similarincreases in ZP
solubility are seen as embryos are cultured for increasinglengths of time
(Coates and Menino, 1994), or the closer to the time of hatching thatembryos67
are removed from the uterus (Domon et al.,1973).This suggests that plasmin
mimicks the effect on the ZP seen during in vitro or in vivo embryo development.
Although this effect is also seen in inactivated plasmin samples at24and48h,
this is again most likely due to the restoration of some of the activity of plasmin.
It is unknown why the AEBSF used in these experiments is incapable of
maintaining complete inactivation of plasmin throughout the entire incubation
period. One possible explanation is that AEBSF may have a relatively short half-
life, and decayed to such an extent over the treatment times usedas to allow
restoration of plasmin activity in treatments. Another explanationmay be that
some degradation of the substrate occurs in the active site, and over the
treatment times used this degradation was sufficient to decrease the functional
concentration of inhibitor in the samples.
Keski-Oja and Vaheri(1982)demonstrated that u-PA was capable of
proteolysis of a MW 66,000 matrix protein in the pericellular matices of human
lung fibroblasts. Baron-Van Evercooren and coworkers(1987)have shown that
neurons in developing dorsal root ganglia of the rat secrete u-PA. u-PA hasa
dose-dependent mitogenic effect on Schwann cells and this effectoccurs in the
absence of plasminogen, suggesting that the substrate for PA in thissystem is
not plasminogen. It was therefore suspected that the bovine embryonic PAitself
might be capable of using the ZP as a substrate, thereby catalyzingproteolysis
of the ZP independent of indirect effects through activation ofplasminogen.
Embryonic PA does not seem to use the bovine ZPas a substrate, however, as
no changes in major polypeptide bands were observed, and ZP solubilitywas
not different for ZP incubated in non-conditioned mediumversus embryo-
conditioned medium. In samples in which embryo-conditioned mediumwas
combined with human plasminogen, results similar to treatmentof ZP with68
plasmin were observed in the ZP polypeptide profiles, suggesting that the
bovine embryonic PA is capable of catalyzing indirect alteration of the bovine ZP
through activation of plasminogen to plasmin.
The results of these experiments have physiological significance with
particular respect to the mechanisms involved in fertilization and hatching. Much
research has been performed on the specific actions of acrosin on the ZP
components, with the concept in mind that acrosin is an absolute requirement
for sperm to penetrate the ZP. However, it was recently demonstrated that
acrosin is not an absolute requirement for fertilization. Baba and coworkers
(1994) used a transgenic mouse model in which the acrosin gene was mutated
and made non-functional to examine the role of acrosin in fertilization. It was
shown that although the sperm cells had no acrosin activity, the mice were still
fertile. In vitro it was demonstrated that sperm from these mice penetrated the
ZP more slowly than sperm from normal mice, suggesting that although acrosin
plays a role in sperm penetration of the ZP,itis not the sole protease
responsible for sperm penetration.
It has also been demonstrated that both murine gametes are capable of
activating plasminogen. Oocytes secrete t-PA (Huarte et al., 1985), and sperm
cells posses receptors for u-PA (Huarte et al., 1987). Both gametes are capable
of activating plasminogen to plasmin, and addition of plasminogen to in vitro
fertilization medium enhanced sperm binding to and penetration of the ZP
(Huarte et al., 1993). Since we have shown from the present study that plasmin
is capable of proteolytically degrading the ZP, this may be a mechanism used by
the sperm cell to penetrate the oocyte. Sperm cells may activate plasminogen to
plasmin through receptor bound u-PA on the cell surface, and thereby direct
localized proteolysis of the ZP as they penetrate the ZP during fertilization.69
Bovine embryos produce a u-PA (Berg and Menino, 1992) andare
capable of activating plasminogen to plasmin (Menino and Williams, 1987).
Since plasminogen is present in the uterine environment (Finlay et al., 1983;
Fazleabas et al., 1983), this represents a readily availablesource of proteolytic
activity to degrade the ZP. Also, since embryos which producemore total PA are
more likely to hatch (Kaaekuahiwi and Menino, 1990), this suggests that greater
proteolytic activity on the ZP prior to hatching is advantageous.
The major force responsible for rupture of the ZP during hatchingseems
to be mechanical pressure generated by the expanding blastocoel. Inhibition of
blastocoelic expansion willinhibit hatching (Coates and Menino,1994).
However, it has been observed in the mouse that ZP from embryos whichhave
hatched have proteolytic activity associated with the ZP, with thegreatest activity
at the site of rupture of the ZP (Perona and Wassarman, 1986). Also,as the time
of hatching approaches, the mouse embryo secretes this proteolyticenzyme,
called strypsin, in increasing amounts (Sawada et al.,1990). Activation of
plasminogen to plasmin by the bovine embryomay be a mechanism used to
cause proteolytic degradation of the ZP, which would weaken it and facilitate
hatching. Since plasmin is capable of proteolytic degradationof the ZP which
results in increased ZP solubility, the PA/plasmin systemmay be used by the
embryo to cause a "sublytic" weakening of the ZP, making it easierfor the
embryo to rupture the ZP during the hatching process.
In summary, plasmin is capable of altering the polypeptideprofile and
structural integrity of the ZP. It is unlikely that the embryonicPA has a direct
proteolytic affect on the ZP. However, through activation ofplasminogen, the
embryonic PA can indirectly induce alterations in the ZP.70
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CONCLUSION
SDS-PAGE of bovine ZP in these experiments resulted in the resolution of
two major bands with MW approximately 76,000 and 65,000, and two minor
bands with MW 23,000 and 22,000. The results of plasmin treatment of ZP
indicate that plasmin is capable of proteolytically degrading the ZP. ZP treated
with physiologic concentrations of plasmin (100µg /ml) for 24 or 48 h show
definite alterations in the major polypeptide bands presenton SDS-PAGE gels
when compared with ZP incubated with 0 µg /ml plasmin. Furthermore,
treatment of ZP with 200 µg /ml plasmin for 24 h results in alterations of the
major polypeptide bands similar to that seen in thepresence of 100 µg /ml
plasmin, however the effect is much more pronounced. The polypeptidesmost
susceptible to proteolytic degradation by plasmin seem to be the MW 76,000
major polypeptide, and the MW 22,000 and 23,000 minor doublet.Appearance
of a diffuse band with approximate MW 45,000-50,000 presumably reflectsa
degradation product of the MW 76,000 component, whichseems to be the more
susceptible of the two high MW polypeptides to plasmin degradation.
It was also suspected that the bovine embryonic PA itself mightbe
capable of using the ZP as a substrate, thereby catalyzing proteolysisof the ZP
independent of indirect effects through activation of plasminogen.Embryonic PA
does not seem to use the bovine ZP as a substrate, however,as no changes in
major polypeptide bands were observed, and ZP solubilitywas not different for
ZP incubated in non-conditioned medium versus embryo-conditionedmedium.
In samples in which embryo-conditioned mediumwas combined with human
plasminogen, results similar to treatment of ZP with plasminwere observed in75
the ZP polypeptide profiles, suggesting that the bovine embryonicPA is capable
of catalyzingindirectalterationof the bovine ZP through activationof
plasminogen to plasmin.
The biochemical alteration of the ZP by plasmin has beenshown to have
physiological significance. The zona pellucida dissolutionassays conducted in
these experiments demonstrate that the proteolytic alterationof the ZP
polypepetides results in increased solubility of the ZP.
The results of these experiments have physiological significancewith
particular respect to the mechanisms involved in fertilization andhatching. Since
we have shown from the present study that plasmin is capable of proteolytically
degrading the ZP, this may be a mechanism used by thesperm cell to penetrate
the oocyte. Activation of plasminogen to plasmin by the bovineembryo may be
a mechanism used to cause proteolytic degradation of the ZP, which would
weaken it and facilitate hatching. Since plasmin iscapable of proteolytic
degradation of the ZP which results in increased ZP solubility,the PA/plasmin
system may be used by the embryo to causea "sublytic" weakening of the ZP,
making it easier for the embryo to rupture the ZP duringthe hatching process.
In summary, plasmin is capable of altering the polypeptideprofile and
structural integrity of the ZP. It is unlikely that the embryonicPA has a direct
proteolytic affect on the ZP. However, through activationof plasminogen, the
embryonic PA can indirectly induce alterations in the ZP.76
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